Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 29, 2021 Medical Device Investing
Hollister Biosciences Inc. Announces Exclusive Distribution Partnership with Nabis for Expanded Market Reach Across California Psychedelics Investing
AbbVie Announces Extension of Review for Supplemental New Drug Application of Upadacitinib for the Treatment of Moderate to Severe Atopic Dermatitis Biotech Investing
INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Biotech Investing
BLU INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff in a Securities Class Action Lawsuit Against BELLUS Health, Inc. Biotech Investing
BLU LOSS ALERT: ROSEN A TOP RANKED INVESTOR RIGHTS LAW FIRM, Encourages BELLUS Health Inc. Investors with LARGE LOSSES to Secure Counsel Before Important Deadline in Securities Class Action - BLU Biotech Investing
Pfizer Invites Public to Register for Webcast of Analyst and Investor Call to Review Oncology Business on April 9, 2021 Pharmaceutical Investing
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
